Details for New Drug Application (NDA): 214010
✉ Email this page to a colleague
The generic ingredient in AMPHOTERICIN B is amphotericin b. There are fifteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the amphotericin b profile page.
Summary for 214010
Tradename: | AMPHOTERICIN B |
Applicant: | Eugia Pharma |
Ingredient: | amphotericin b |
Patents: | 0 |
Suppliers and Packaging for NDA: 214010
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
AMPHOTERICIN B | amphotericin b | INJECTABLE, LIPOSOMAL;INJECTION | 214010 | ANDA | Eugia US LLC | 55150-365 | 55150-365-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (55150-365-01) / 12.5 mL in 1 VIAL, SINGLE-DOSE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE, LIPOSOMAL;INJECTION | Strength | 50MG/VIAL | ||||
Approval Date: | Nov 17, 2022 | TE: | AB | RLD: | No |
Complete Access Available with Subscription